Struma ovarii with atypical features and synchronous primary thyroid cancer: a case report and review of the literature.

Arch Gynecol Obstet

Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, Molly Siegel 550 16th Street, 7th Floor, Ob/Gyn Mailstop 0132, San Francisco, CA, 94143, USA.

Published: December 2019


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Purpose: To present a case of struma ovarii with a typical features and synchronous primary thyroid carcinoma and review the available literature to guide diagnosis and management of these tumors.

Methods: We present a case from our hospital of a 55-year-old woman who had an adnexal mass with features concerning for papillary thyroid carcinoma and was ultimately determined to be struma ovarii with atypical features. Subsequent thyroid imaging and biopsy revealed a primary cervical thyroid carcinoma. We performed a PubMed search of published English language articles using the search terms "malignant struma ovarii," "metastatic struma ovarii," "struma ovarii with malignant transformation," "struma ovarii papillary thyroid carcinoma," "struma ovarii follicular thyroid carcinoma," and "struma ovarii with concurrent primary thyroid carcinoma."

Results: Literature review included 104 studies with a total of 195 patient cases. The average age at presentation was 44.9 years. 25.1% of patients had metastatic disease at presentation, and 6.2% had synchronous primary carcinomas; all of which were located in the thyroid.

Conclusions: Thyroid carcinoma arising in struma ovarii or mature cystic teratoma should prompt clinical evaluation and imaging of the thyroid given the possibility of synchronous primaries, metastases, and recurrence.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00404-019-05329-zDOI Listing

Publication Analysis

Top Keywords

struma ovarii
16
thyroid carcinoma
16
"struma ovarii
16
synchronous primary
12
primary thyroid
12
thyroid
10
ovarii atypical
8
atypical features
8
features synchronous
8
review literature
8

Similar Publications

Struma ovarii (SO) is a rare form of ovarian teratoma predominantly composed of thyroid tissue. While most cases follow a benign course, some may exhibit malignant transformation or extra-ovarian spread. We present the case of a 43-year-old woman with a history of SO previously treated with right oophorectomy and systemic chemotherapy, along with a separate diagnosis of papillary thyroid carcinoma managed with total thyroidectomy and radioactive iodine ablation.

View Article and Find Full Text PDF

Rationale: Struma ovarii is a rare form of mature cystic teratoma, with malignant transformation reported in approximately 5% to 10% of cases. Transformation into follicular thyroid carcinoma (FTC) is extremely uncommon; as a result, no standardized guidelines exist for treatment or prognosis for such cases.

Patient Concerns: A 54-year-old woman with cholelithiasis presented with upper abdominal discomfort.

View Article and Find Full Text PDF

Diagnosis and Management of Struma Ovarii in Pregnancy: A Case Report.

Life (Basel)

August 2025

Obstetrics and Gynecology Department, Hospital Materno-Infantil, Hospital Regional Universitario Málaga, Avenida Arroyo de los Ángeles S/N, 29011 Málaga, Spain.

Adnexal tumors during pregnancy are rare, with a prevalence ranging from 0.05% to 3%, and in most cases, they are benign. Struma ovarii, a monodermal teratoma, consists of over 50% thyroid tissue and accounts for 2.

View Article and Find Full Text PDF

Struma ovarii (SO) is a rare ovarian teratoma with predominant thyroid tissue. Malignant SO (MSO) occurs in 5%-10% of cases, with papillary and follicular thyroid carcinomas being the most common malignant types. The disease is typically diagnosed in women aged 40-60 years, and management protocols are not well defined due to its rarity.

View Article and Find Full Text PDF

Gynaecological tumours present a broad spectrum of histological subtypes due to the diverse anatomical and tissue origin of the reproductive organs. Rare tumours affect less than 6 per 100,000 individuals annually, posing significant challenges in diagnosis and management due to limited clinical awareness. Indeed, treatment protocols rely on options developed for more common histotypes, which may have limited efficacy on these rare tumours.

View Article and Find Full Text PDF